BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10422892)

  • 1. Different effects of L-type and T-type calcium channel blockers on the hypnotic potency of triazolam and zolpidem in rats.
    Takahashi H; Yoshimoto M; Higuchi H; Shimizu T; Hishikawa Y
    Eur Neuropsychopharmacol; 1999 Jun; 9(4):317-21. PubMed ID: 10422892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of benzodiazepine (triazolam), cyclopyrrolone (zopiclone) and imidazopyridine (zolpidem) hypnotics on the frequency of hippocampal theta activity and sleep structure in rats.
    Yoshimoto M; Higuchi H; Kamata M; Yoshida K; Shimizu T; Hishikawa Y
    Eur Neuropsychopharmacol; 1999 Jan; 9(1-2):29-35. PubMed ID: 10082225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perturbation of ion channel conductance alters the hypnotic response to the alpha 2-adrenergic agonist dexmedetomidine in the locus coeruleus of the rat.
    Nacif-Coelho C; Correa-Sales C; Chang LL; Maze M
    Anesthesiology; 1994 Dec; 81(6):1527-34. PubMed ID: 7992922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of daytime administration of zolpidem versus triazolam on memory.
    Wesensten NJ; Balkin TJ; Belenky GL
    Eur J Clin Pharmacol; 1995; 48(2):115-22. PubMed ID: 7589024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nifedipine, an L-type calcium channel blocker, restores the hypnotic response in rats made tolerant to the alpha-2 adrenergic agonist dexmedetomidine.
    Reid K; Guo TZ; Davies MF; Maze M
    J Pharmacol Exp Ther; 1997 Dec; 283(3):993-9. PubMed ID: 9399968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of chronic treatment with triazolam on operant responding in rats.
    Cohen C; Sanger DJ
    Pharmacol Biochem Behav; 1994 Nov; 49(3):455-61. PubMed ID: 7862694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of hypnotics on the sleep EEG of healthy young adults: new data and psychopharmacologic implications.
    Feinberg I; Maloney T; Campbell IG
    J Psychiatr Res; 2000; 34(6):423-38. PubMed ID: 11165310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hypnotics triazolam and zolpidem have identical metabolic effects throughout the brain: implications for benzodiazepine receptor subtypes.
    Piercey MF; Hoffmann WE; Cooper M
    Brain Res; 1991 Jul; 554(1-2):244-52. PubMed ID: 1657289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited anxiolytic-like effects of non-benzodiazepine hypnotics in rodents.
    Griebel G; Perrault G; Sanger DJ
    J Psychopharmacol; 1998; 12(4):356-65. PubMed ID: 10065909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A selective T-type Ca2+ channel blocker R(-) efonidipine.
    Shin MC; Kim CJ; Min BI; Ogawa S; Tanaka E; Akaike N
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):411-21. PubMed ID: 18278483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the daytime sleep and performance effects of zolpidem versus triazolam.
    Balkin TJ; O'Donnell VM; Wesensten N; McCann U; Belenky G
    Psychopharmacology (Berl); 1992; 107(1):83-8. PubMed ID: 1589566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute behavioral effects and abuse potential of trazodone, zolpidem and triazolam in humans.
    Rush CR; Baker RW; Wright K
    Psychopharmacology (Berl); 1999 Jun; 144(3):220-33. PubMed ID: 10435388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleep-related vagotonic effect of zolpidem in rats.
    Chen HY; Kuo TB; Shaw FZ; Lai CJ; Yang CC
    Psychopharmacology (Berl); 2005 Sep; 181(2):270-9. PubMed ID: 15778879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zolpidem is differentiated from triazolam in humans using a three-response drug discrimination procedure.
    Mintzer MZ; Frey JM; Griffiths RR
    Behav Pharmacol; 1998 Nov; 9(7):545-59. PubMed ID: 9862080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of zolpidem, a new imidazopyridine hypnotic, on the acquisition of conditioned fear in mice. Comparison with triazolam and CL 218,872.
    Sanger DJ; Joly D; Zivkovic B
    Psychopharmacology (Berl); 1986; 90(2):207-10. PubMed ID: 2878460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans.
    Rush CR; Madakasira S; Goldman NH; Woolverton WL; Rowlett JK
    J Pharmacol Exp Ther; 1997 Jan; 280(1):174-88. PubMed ID: 8996195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of nilvadipine on the voltage-dependent Ca2+ channels in rat hippocampal CA1 pyramidal neurons.
    Ishibashi H; Murai Y; Akaike N
    Brain Res; 1998 Nov; 813(1):121-7. PubMed ID: 9824683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triazolam and zolpidem: effects on human memory and attentional processes.
    Mintzer MZ; Griffiths RR
    Psychopharmacology (Berl); 1999 May; 144(1):8-19. PubMed ID: 10379619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triazolam and zolpidem: a comparison of their psychomotor, cognitive, and subjective effects in healthy volunteers.
    Mintzer MZ; Frey JM; Yingling JE; Griffiths RR
    Behav Pharmacol; 1997 Nov; 8(6-7):561-74. PubMed ID: 9832970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of zolpidem and triazolam on memory functions, psychomotor performances, and postural sway in healthy subjects.
    Berlin I; Warot D; Hergueta T; Molinier P; Bagot C; Puech AJ
    J Clin Psychopharmacol; 1993 Apr; 13(2):100-6. PubMed ID: 8463441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.